Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...